Rif1 Activators comprise a class of chemical compounds that play a pivotal role in activating and modulating the function of Rif1, a protein involved in various cellular processes. These activators exert their effects by directly or indirectly stimulating intracellular signaling pathways, including Akt, JNK, PI3K/Akt, and PKC pathways, which are associated with Rif1 activity. One subset of Rif1 activators, such as MK-2206 and sc-12, focus on the Akt pathway. Their activation enhances downstream signaling events, indirectly influencing Rif1 by promoting the activation of pathways associated with Akt. Similarly, compounds like SB-239063 and JNK-IN-8 (Alternative) directly stimulate the JNK pathway, leading to the modulation and activation of Rif1 through downstream signaling events within the JNK pathway.
Another group of Rif1 activators, including PIK-90 and GDC-0941 (Alternative), specifically target the PI3K/Akt pathway. Their activation directly influences Rif1 by promoting downstream signaling cascades that activate the protein. Additionally, activators like PMA and Go 6983 focus on the PKC pathway. Their activation indirectly leads to the activation of Rif1 by influencing downstream signaling events within the PKC pathway. Furthermore, compounds like AZD8330 and RDEA119 (Alternative) concentrate on the MAPK/ERK pathway. Their activation indirectly influences Rif1 by enhancing activity within the MAPK pathway. Moreover, PI-103 (Alternative) targets both PI3K and mTOR, leading to the activation of the PI3K/Akt pathway and consequently influencing Rif1 activity. In summary, Rif1 Activators represent a diverse class of chemical compounds that play a crucial role in activating and modulating Rif1 within the cellular context. Their ability to directly or indirectly stimulate relevant intracellular signaling pathways makes them valuable tools for studying the regulatory mechanisms governing Rif1 and its involvement in cellular processes. These activators provide insights into the intricate network of signaling events that govern Rif1's function, contributing to a deeper understanding of its cellular roles.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an Akt activator that enhances the Akt pathway, indirectly influencing Rif1 by promoting downstream signaling cascades associated with the Akt pathway. | ||||||
SB 239063 | 193551-21-2 | sc-220094B sc-220094 sc-220094A | 500 µg 5 mg 25 mg | $119.00 $162.00 $645.00 | 7 | |
SB-239063 is a JNK activator that directly stimulates the JNK pathway. Its activation results in the modulation and activation of Rif1 through downstream signaling events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that activates the PKC pathway. Its activation indirectly leads to the activation of Rif1 by influencing downstream signaling events within the PKC pathway. | ||||||
AZD8330 | 869357-68-6 | sc-364425 sc-364425A | 5 mg 10 mg | $255.00 $450.00 | ||
AZD8330 is a MEK1/2 activator that specifically enhances the MAPK/ERK pathway. Its activation indirectly results in the modulation and activation of Rif1 within the cell. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a PI3K activator that enhances the PI3K/Akt pathway. Its activation directly impacts Rif1 by facilitating downstream signaling cascades that activate the protein. | ||||||
JNK Inhibitor XVI | 1410880-22-6 | sc-364745 | 10 mg | $357.00 | 5 | |
JNK Inhibitor XVI is a JNK activator that directly stimulates the JNK pathway. Its activation leads to the activation of Rif1 through modulation of downstream signaling events. | ||||||
BAY 869766 | 923032-37-5 | sc-364427 sc-364427A | 5 mg 10 mg | $245.00 $428.00 | 1 | |
BAY 869766 is a MEK1 activator that specifically targets the MAPK/ERK pathway. Its activation indirectly influences Rif1 by promoting activity within the MAPK pathway. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 (Alternative) is a PI3K/mTOR activator that enhances the PI3K/Akt pathway. Its activation directly impacts Rif1 by facilitating downstream signaling cascades that activate the protein. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a PKC activator that activates the PKC pathway. Its activation indirectly leads to the activation of Rif1 by influencing downstream signaling events within the PKC pathway. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a MEK1/2 activator that specifically enhances the MAPK/ERK pathway. Its activation indirectly results in the modulation and activation of Rif1 within the cell. | ||||||